Broad Consent-Are We Asking Enough?

Area of Science:

• Biomedical research
• Health data science
• Biobanking ethics

Background:

• Biobanks and health data repositories are crucial for biomedical research.
• Participant data and biospecimens are often used indefinitely for various research purposes.
• Informed consent has been a requirement for federally funded human subjects research since 1991.

Purpose of the Study:

• To analyze the implications of recent changes to the U.S. Common Rule regarding broad consent in biobanking and health data repositories.
• To highlight the absence of a clear definition for broad consent and its potential consequences.

Main Methods:

• Analysis of U.S. federal regulatory provisions (the Common Rule).
• Examination of the concept of "broad consent" in the context of research repositories.
• Assessment of the potential impact of undefined regulatory terms on participant protections.

Main Results:

• Recent revisions to the Common Rule now allow for broad consent in repository research.
• The revised Common Rule does not define "broad consent," creating ambiguity for researchers and institutions.
• A lack of federal guidance may result in varied institutional standards for consent.

Conclusions:

• The absence of a clear definition for broad consent poses a risk to participant protections.
• Uneven standards for consent may emerge without federal leadership and guidance.
• Further clarification is needed to ensure consistent and adequate protection for research participants.